| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥18.92B | -6.6% |
| Gross profit | ¥7.48B | — |
| Operating income | ¥5.26B | — |
| Net income | ¥4.14B | -32.9% |
| Gross margin | 39.5% | Net margin 21.9% |
| Revenue Q/Q | -7.4% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥11.45B | 60.5% |
| R&D | ¥0.06B | 0.3% |
| SG&A | ¥0.81B | 4.3% |
| Tax & other | ¥1.12B | 5.9% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
中国银行 ・ 中金公司 ・ 中信银行 ・ 中科曙光 ・ 药明康德 ・ 合盛硅业 ・ 海天味业 ・ 华勤技术 ・ 今世缘 ・ 万泰生物 ・ 豪威集团 ・ 华友钴业
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies